angiotensin-receptor blocker


Also found in: Medical.

angiotensin-receptor blocker:

see under ACE inhibitorACE inhibitor
or angiotensin-converting enzyme inhibitor
, drug used to reduce elevated blood pressure (see hypertension), to treat congestive heart failure, and to alleviate strain on hearts damaged as a result of a heart attack (see infarction).
..... Click the link for more information.
.
References in periodicals archive ?
The researchers excluded patients already taking an angiotensin-receptor blocker or angiotensin-converting enzyme inhibitor.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
proteinuria or symptomatic left ventricular systolic dysfunction despite treatment with and ACE inhibitor or an angiotensin-receptor blocker alone," said Dr.
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
ACE = angiotensin-converting enzyme; ARB = angiotensin-receptor blocker.
For example, 92 per cent of Kaiser Permanente patients with ACS were discharged with an ACE inhibitor(3) or angiotensin-receptor blocker (ARB)(4), recommended in the guidelines as an effective therapy for reducing mortality from heart attacks.
The FDA's Cardiovascular and Renal Drugs Advisory Committee voted unanimously against approving the angiotensin-receptor blocker for reducing the risk of MI, stroke, cardiovascular deaths, or hospitalization for heart failure in patients 55 years or older at high risk of developing major cardiovascular events.
To start treatment according to the algorithm, which called for a low dose (half tablet) of a marketed formulation that combined a diuretic with either an angiotensin-converting enzyme inhibitor or an angiotensin-receptor blocker, physicians could choose among 11 formulations that were on the Canadian market at the time the study began.
Aliskiren failed to produce additional blood pressure lowering when it was added to an angiotensin-receptor blocker (valsartan).
Treatment of heart failure typically begins with an ACE inhibitor or an angiotensin-receptor blocker, mainly for historic reasons: ACE inhibitors were proven effective for treating heart failure first.
Most patients were also treated with an ACE inhibitor or an angiotensin-receptor blocker, and most were also treated with a diuretic.
The 15,245-patient study, designed to show the efficacy of the angiotensin-receptor blocker valsartan, confirmed the value of calcium channel blockers (CCBs) by showing that both drugs reduced blood pressure (mean reduction of 17.

Full browser ?